Black Rock Inc. Vbi Vaccines Inc Transaction History

Black Rock Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.29 - $0.64 $167,818 - $370,358	-578,685 Reduced 4.33%	12,781,090 $3.83 Million
Q4 2022 Feb 13, 2023	SELL	$0.38 - $22.5 $36,729 - $2.17 Million	-96,656 Reduced 0.72%	13,359,775 $5.21 Million
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $183,427 - $5.88 Million	-251,271 Reduced 1.83%	13,456,431 $9.5 Million
Q2 2022 Aug 12, 2022	BUY	$0.66 - $1.81 $321,152 - $880,735	486,594 Added 3.68%	13,707,702 $11.1 Million
Q1 2022 May 12, 2022	SELL	$1.27 - $2.47 $61,103 - $118,839	-48,113 Reduced 0.36%	13,221,108 $21.9 Million
Q4 2021 Feb 10, 2022	BUY	$2.21 - $3.22 $1.02 Million - $1.49 Million	462,785 Added 3.61%	13,269,221 $31 Million
Q3 2021 Nov 09, 2021	SELL	$2.8 - $3.72 $213,474 - $283,616	-76,241 Reduced 0.59%	12,806,436 $39.8 Million
Q2 2021 Aug 11, 2021	BUY	$2.61 - $4.17 $33.6 Million - $53.7 Million	12,882,677 New	12,882,677 $43.2 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.